NeuroSense Collaborates with Lonza on Biomarkers of Neurodegenerative Disease

 

• NeuroSense will leverage its extensive experience in biomarker utilization to advance early diagnosis and treatment in the neurodegeneration field
• Lonza to develop, optimize, and qualify a method utilizing Neuron-Derived Exosomes ("NDEs"), set to be integrated into the clinical development program of PrimeC by NeuroSense
• Lonza's Dev-on-Demand solution to enable NeuroSense to access Lonza's process development with rapid initiation, execution, and delivery of work

https://www.prnewswire.com/news-releases/neurosense-collaborates-with-lonza-to-identify-exosome-based-biomarkers-in-order-to-advance-neurodegenerative-disease-treatments-and-diagnostics-302111745.html